Search For "trial"
Hoping to get 1000 volunteers for Covaxin trial, says PGIMS V-C
Updated : 5 years, 4 months ago IST
Rohtak (Haryana) [India], November 19 (ANI): Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences (PGIMS), Rohtak, hopes to get 1,000 healthy volunteers by Thursday for the third-phase trial of Bharat Biotech's COVID-19 vaccine candidate, Covaxin, that will begin from F
Read More
Spain authorizes Phase 3 clinical trials of Janssen's COVID-19 vaccine
Updated : 5 years, 4 months ago IST
Madrid [Spain], November 18 (ANI/Sputnik): The Spanish Agency of Medicines and Medical Devices (AEMPS) authorized phase 3 clinical trials of the COVID-19 vaccine developed by Janssen, a subsidiary of the Johnson & Johnson company, the Spanish Health Ministry said on Wednesday.
Read More
Pfizer says Covid-19 vaccine trial complete, cites shot is 95 per cent eff
Updated : 5 years, 4 months ago IST
Washington [US], November 18 (ANI): American drug giant Pfizer on Wednesday said that final results from the late-stage trial of its coronavirus vaccine was found to be 95 per cent effective and had no serious side effects on older people.
Read More
Anil Vij offers to be 'first volunteer' for Phase-III trial of Covaxin in
Updated : 5 years, 4 months ago IST
New Delhi [India], November 18 (ANI): Haryana Health Minister Anil Vij has offered to become the "first volunteer" for Phase-III clinical trial of Bharat Biotech's COVID-19 vaccine 'Covaxin', which will begin in Haryana from November 20.
Read More
Rajnath Singh congratulates DRDO for successful trials of QRSAM
Updated : 5 years, 4 months ago IST
New Delhi [India], November 17 (ANI): Defence Minister Rajnath Singh on Tuesday congratulated the Defence Research Development Organisation (DRDO) for two back to back successful test trials of Quick Reaction Surface to Air Missile (QRSAM).
Read More
Bharat Biotech starts phase III trials for COVAXIN
Updated : 5 years, 4 months ago IST
Hyderabad [India], November 17, (ANI): Bharat Biotech announced the commencement of Phase III trials of COVAXIN on Monday.
Read More
Indian govt in talks with Moderna for its COVID-19 vaccine candidate
Updated : 5 years, 4 months ago IST
New Delhi[India], Nov 16 (ANI) Indian government is in dialogue with US biotech giant Moderna, regarding initial successful development of its COVID-19 vaccine candidate, which the drugmaker on Monday announced had achieved 94.5 per cent efficacy in phase 3 trials.
Read More
Encouraged to hear Moderna's efficacy results of COVID-19 vaccine: WHO
Updated : 5 years, 4 months ago IST
Geneva [Switzerland], November 16 (ANI/Sputnik): The World Health Organization (WHO) is encouraged to hear the announcement of the US biotech firm, Moderna, about the efficacy results of its coronavirus vaccine during its phase three clinical trials, its press office said on Monday.
Read More
Moderna's Covid-19 vaccine is 94.5 pc effective
Updated : 5 years, 4 months ago IST
Massachusetts [US], November 16 (ANI): US biotech company Moderna on Monday announced a new potential Covid-19 vaccine, which has been shown to be 94.5 per cent effective at protecting people from coronavirus, according to interim results from late-stage clinical trials.
Read More
Kerala HC extends interim stay order of trial in Kerala actress attack cas
Updated : 5 years, 4 months ago IST
Kochi (Kerala) [India], November 16 (ANI): Kerala High Court has extended till this Friday the interim stay order of the trial in the Kerala actress case. Court will pronounce the order on Friday. Justice VG Arun gave the order while considering the transfer applications filed by the prosecu
Read More
Study reveals walnuts helpful in cardiovascular disease
Updated : 5 years, 4 months ago IST
Washington [US], November 15 (ANI): Studies from a randomised controlled trial reveals the capability of walnuts from preventing major risk factors for heart disease, claims,' people who regularly consume walnuts may have a lower risk of heart disease, compared to those who do not eat'.
Read More
COVISHIELD completes enrolment of Phase III clinical trials under ICMR, SI
Updated : 5 years, 4 months ago IST
New Delhi [India], November 12 (ANI): The Serum Institute of India (SII) and Indian Council of Medical Research (ICMR) have announced the completion of enrolment of phase 3 clinical trials for COVISHIELD in India.
Read More